bortezomib

The drug is used for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XX32

Manufacturer: Eugia Pharma Specialities Limited

The drug is used for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy, depending on the stage of the disease) and mantle cell lymphoma.

Form: lyophilisate for solution for injection

ATC: L01XX32

Manufacturer: Hetero Labs Limited

The drug is prescribed for the treatment of progressive multiple myeloma (either as monotherapy or in combination with other agents), mantle cell lymphoma, as well as light chain amyloidosis.

Form: lyophilisate for solution for injection

ATC: L01XG01

Manufacturer: San Pharmaceutical Industries Ltd.

The drug is prescribed for the treatment of multiple myeloma (in both treatment-naïve patients and in cases of disease progression), as well as for the treatment of mantle cell lymphoma.

Form: powder, lyophilized for injection solution

ATC: L01XG01

Manufacturer: Farmideya LLC

The drug is used for the treatment of multiple myeloma (either as monotherapy or in combination with other medicines) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XX32

Manufacturer: Oncomed Manufacturing a.s. (manufacturing, packaging)

The drug is used for the treatment of multiple myeloma (as monotherapy or in combination with other drugs) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XX32

Manufacturer: Oncomed Manufacturing a.s. (manufacturing, packaging)

The drug is used for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XX32

Manufacturer: Oncomed Manufacturing a.s. (manufacturing, packaging)

The drug is prescribed for the treatment of progressive multiple myeloma in adults, as well as for the treatment of mantle cell lymphoma.

Form: solution for injection

ATC: L01XG01

Manufacturer: EVER Pharma Jena GmbH (manufacture of unpackaged product, primary packaging, quality control testing, batch release; secondary packaging, labeling, quality control testing, batch release)

The drug is prescribed for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.

Form: powder for injection, lyophilized for preparation of solution for injection

ATC: L01XG01

Manufacturer: MSN Laboratories Private Limited

The drug is used for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy), as well as for the treatment of mantle cell lymphoma.

Form: lyophilisate for solution for injection

ATC: L01XG01

Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))

The drug is used for the treatment of multiple myeloma (as part of combination therapy or as monotherapy) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XG01

Manufacturer: Baxter Oncology GmbH

The drug is used for the treatment of adult patients with multiple myeloma (either as monotherapy or in combination with other agents), as well as for the treatment of mantle cell lymphoma.

Form: solution for injection

ATC: L01XG01

Manufacturer: Accord Healthcare Polska Sp. z o.o. Warehouse Importer (Responsible for batch release)

The drug is used for the treatment of multiple myeloma (as part of combination therapy or as monotherapy depending on the stage of the disease) and mantle cell lymphoma.

Form: lyophilisate for solution for injection

ATC: L01XG01

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

The drug is prescribed for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy, depending on the stage), as well as for the treatment of mantle cell lymphoma.

Form: lyophilisate for solution for injection

ATC: L01XG01

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

The drug is prescribed for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XG01

Manufacturer: ALKALOID AD Skopje (batch release)

The drug is used for the treatment of multiple myeloma (as part of combination therapy or as monotherapy) and mantle cell lymphoma.

Form: powder for injection solution

ATC: L01XG01

Manufacturer: ALKALOID AD Skopje (batch release)

The drug is used for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.

Form: lyophilisate for solution for injection

ATC: L01XX32

Manufacturer: Reliance Life Sciences Private Limited

The drug is used for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.

Form: lyophilisate for solution for injection

ATC: L01XX32

Manufacturer: Reliance Life Sciences Private Limited